DENVER, CO / ACCESSWIRE / March 28, 2019 / Nexien BioPharma, Inc. (“Nexien” or the “Company”) (OTCQB: NXEN), a next generation biopharmaceutical company focused on research, development, and commercialization of advanced FDA Compliant cannabinoid pharmaceuticals and related drug delivery systems, today announced that its management will present at The MicroCap Conference Spring Investor Summit in New York City on Tuesday, April 2, 2019.
Alex Wasyl, Chief Executive Officer, is scheduled to present at 3:00 p.m. ET and will be available for one-on-one meetings with attendees throughout the day. A copy of the investor presentation will be available in the investor relations section of Nexien’s website at https://nexienbiopharma.com/investors.
CONFERENCE OVERVIEW AND STRUCTURE
The Spring Investor Summit (formerly The MicroCap Conference) is an exclusive event dedicated to connecting small and micro cap companies with high-level, institutional and retail investors. The Spring Investor Summit will take place in New York City at the Essex House on April 1st and 2nd. The upcoming conference will feature 200 presenting companies, 1200 institutional and retail investors, 2000 one-on-one meetings, expert speakers, and industry panels.
REGISTRATION FOR INVESTORS
To request free registration, please go to our website (www.springinvestorsummit.com), and click the “Registration” button
PARTICIPATING COMPANIES
For our most updated list of companies, please go to our website (www.springinvestorsummit.com)
About Nexien BioPharma Inc.
Nexien BioPharma is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid pharmaceuticals in accordance with U.S. Food and Drug Administration (“FDA”) pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. For more information, visit Nexien BioPharma’s website at: www.nexienbiopharma.com.
Contacts
Nexien BioPharma, Inc.
info@nexienbiopharma.com
The Equity Group
Kalle Ahl, CFA
(212) 836-9614
kahl@equityny.com
Devin Sullivan
(212) 836-9608
dsullivan@equityny.com
SOURCE: Nexien BioPharma, Inc.
View source version on accesswire.com:
https://www.accesswire.com/540462/Nexien-BioPharma-to-Present-at-The-MicroCap-Conference-Spring-Investor-Summit-on-Tuesday-April-2nd
NEWARK, N.J., March 26, 2025 /PRNewswire/ -- The New Jersey Innovation Institute (NJII), and Cognome are…
ROSWELL, Ga., March 26, 2025 /PRNewswire/ -- Buds Technology, a leader in innovative care management…
The relationship sets a new standard for AI-driven data preparation: Deliver seamless, end-to-end secure data…
Bridging the gap between hotel and homestays, HotelTonight and Airbnb provide a flexible solution for…
Florida's Technology Leader Launches New Client Services Teams in Orlando and Tampa ORLANDO, Fla., March…
SAN FRANCISCO , March 26, 2025 /PRNewswire/ -- In a bold move to strengthen emergency…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="600px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
